Group One Trading’s Aegerion Pharmaceuticals AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-31,600
| Closed | -$94K | – | 5195 |
|
|
2016
Q3 | $94K | Sell |
31,600
-14,500
| -31% | -$25.1K | ﹤0.01% | 2963 |
|
|
2016
Q2 | $69K | Buy |
46,100
+40,100
| +668% | +$91.7K | ﹤0.01% | 3108 |
|
|
2016
Q1 | $22K | Sell |
6,000
-31,500
| -84% | -$195K | ﹤0.01% | 3705 |
|
|
2015
Q4 | $379K | Sell |
37,500
-50,400
| -57% | -$607K | ﹤0.01% | 2033 |
|
|
2015
Q3 | $1.2M | Buy |
87,900
+44,100
| +101% | +$785K | 0.02% | 1112 |
|
|
2015
Q2 | $831K | Sell |
43,800
-91,700
| -68% | -$1.98M | 0.01% | 1366 |
|
|
2015
Q1 | $3.55M | Buy |
135,500
+2,200
| +2% | +$56K | 0.06% | 372 |
|
|
2014
Q4 | $2.79M | Sell |
133,300
-26,200
| -16% | -$660K | 0.04% | 481 |
|
|
2014
Q3 | $5.32M | Buy |
159,500
+9,100
| +6% | +$282K | 0.08% | 271 |
|
|
2014
Q2 | $4.83M | Buy |
150,400
+23,100
| +18% | +$860K | 0.07% | 311 |
|
|
2014
Q1 | $5.87M | Buy |
127,300
+82,300
| +183% | +$4.83M | 0.1% | 187 |
|
|
2013
Q4 | $3.19M | Sell |
45,000
-198,100
| -81% | -$15.1M | 0.05% | 406 |
|
|
2013
Q3 | $20.8M | Sell |
243,100
-64,900
| -21% | -$5.5M | 0.4% | 24 |
|
|
2013
Q2 | $19.5M | Buy |
+308,000
| New | +$16.4M | 0.48% | 22 |
|
Group One Trading's AEGR Position: Q3 2016 in Review
Group One Trading sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2016, closing a stake of 14,362 shares — an estimated $24.9K sold.
Group One Trading first reported a position in AEGR in Q2 2013 and held it in 10 quarters. The position peaked at $4.11M in Q2 2013. 58 funds tracked by Wall St. Rank hold AEGR as of Q3 2016.
- Group One Trading reported no remaining Aegerion Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
- Group One Trading sold 14,362 Aegerion Pharmaceuticals shares in Q3 2016, an estimated $24.9K.
- Group One Trading first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 10 quarters.
- Group One Trading's Aegerion Pharmaceuticals position peaked at $4.11M in Q2 2013.
- 58 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2016.
Based on Group One Trading's 13F filing for Q3 2016, filed 14 Nov 2016.